Opinion

Video

How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

Author(s):

Sara M. Tolaney, MD, MPH

HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Stay up to date on cancer updates, research and education

      Subscribe Now!
      Related Videos
      Imiage of two doctors with text.
      ctDNA-Guided Therapy May Improve Breast Cancer Outcomes
      Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
      Enhertu Combo May Offer Longer Control for HER2+ Breast Cancer
      Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
      Targeting ESR1 Mutations Early May Improve Outcomes in Breast Cancer
      Image of woman.
      Understanding the Side Effects of RLY-2608 in HR+, HER2– Breast Cancer
      Picture of Dr. Pouneh Razavi
      Breast MRI Offers Sensitive Imaging for High-Risk and Diagnosed Patients
      Image of a woman wearing a headband and glasses
      An Expert Breaks Down Lymphedema Following Cancer Care
      Combining Radiation and Breast Reconstruction Strategies in Breast Cancer
      Combining Radiation and Breast Reconstruction Strategies in Breast Cancer
      Image of doctor.
      Shorter Radiation Courses May Improve Breast Reconstruction Outcomes
      Image of woman.
      Research Shines Light on Disparities Across Breast Cancer Care
      Image of Doctor.
      Dr. Sheri Prentiss on Steps for Lymphedema Screening in Breast Cancer
      Related Content
      image of woman.
      June 17th 2025

      From Navigating the Unknown to Building a Movement: My DCIS Journey

      Julia Stalder
      The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.
      FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
      February 5th 2024

      FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

      Alex Biese Brielle Benyon
      One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
      I feel unprepared and overwhelmed after my breast cancer diagnosis, facing treatment like a race, hoping for the strength to reach the finish: © stock.adobe.com
      June 15th 2025

      Running a Race I Never Chose: Life During Cancer

      Avis Yarbrough
      I feel unprepared and overwhelmed after my breast cancer diagnosis, facing treatment like a race, hoping for the strength to reach the finish.
      Cancer Horizons podcast logo
      December 12th 2023

      Conference Highlights from SABCS

      Alex Biese Brielle Benyon
      CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
      Image of debbie.
      June 13th 2025

      Survivorship, the Hardest Part After Cancer?

      Debbie Legault
      Survivorship after cancer can be harder than treatment. My daughter faces lasting side effects, fear, and uncertainty while building a life she hopes to live fully.
      Image of Patti.
      June 12th 2025

      Beyond Treatment: How Support Groups Helped Me Embrace My New Normal

      Patti McGee
      Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.